Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005 Nov;2(11):e298. Epub 2005 Oct 25. Erratum in: PLoS Med. 2006 May;3(5):e298.
Binagwaho A, Pegurri E, Muita J, Bertozzi S Male circumcision at different ages in Rwanda: a cost-effectiveness study. PLoS Med. 2010 Jan 19;7(1):e1000211. doi: 10.1371/journal.pmed.1000211.
Jarrett P, Kliner M, Walley J Early infant male circumcision for human immunodeficiency virus prevention: knowledge and attitudes of women attending a rural hospital in Swaziland, Southern Africa. SAHARA J. 2014;11:61-6. doi: 10.1080/17290376.2014.929530. Epub 2014 Jun 24.
Kalichman SC Neonatal circumcision for HIV prevention: Cost, culture, and behavioral considerations. PLoS Med. 2010 Jan 19;7(1):e1000219. doi: 10.1371/journal.pmed.1000219.
Mugwanya KK, Whalen C, Celum C, Nakku-Joloba E, Katabira E, Baeten JM Circumcision of male children for reduction of future risk for HIV: acceptability among HIV serodiscordant couples in Kampala, Uganda. PLoS One. 2011;6(7):e22254. doi: 10.1371/journal.pone.0022254. Epub 2011 Jul 20.
Tobian AA, Gray RH, Quinn TC Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision. Arch Pediatr Adolesc Med. 2010 Jan;164(1):78-84. doi: 10.1001/archpediatrics.2009.232.
Tobian AA, Gray RH The medical benefits of male circumcision. JAMA. 2011 Oct 5;306(13):1479-80. doi: 10.1001/jama.2011.1431.
Tobian AA, Kigozi G, Wawer MJ, Serwadda D, Quinn TC, Gray RH Herpes simplex virus type-2 assay specificity and male circumcision to reduce herpes simplex virus type-2 acquisition. AIDS. 2013 Jan 2;27(1):147-9. doi: 10.1097/QAD.0b013e32835aa181.
UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med. 2009 Sep;6(9):e1000109. doi: 10.1371/journal.pmed.1000109. Epub 2009 Sep 8. Review. Erratum in: PLoS Med. 2009 Dec;6(12). doi: 10.1371/annotation/f1c3679d-18d8-4fbd-bd3f-59db0b284b19.
Westercamp N, Bailey RC Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav. 2007 May;11(3):341-55. Epub 2006 Oct 20. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
